Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Dr. Reddy's Laboratories Limited before investing.

In this article, we go over a few key elements for understanding Dr. Reddy's Laboratories Limited’s stock price such as:

• Dr. Reddy's Laboratories Limited’s current stock price and volume
• Why Dr. Reddy's Laboratories Limited’s stock price changed recently
• Upgrades and downgrades for RDY from analysts
• RDY’s stock price momentum as measured by its relative strength

About Dr. Reddy's Laboratories Limited (RDY)

Before we jump into Dr. Reddy's Laboratories Limited’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Want to learn more about Dr. Reddy's Laboratories Limited’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Dr. Reddy's Laboratories Limited.

Dr. Reddy's Laboratories Limited’s Stock Price as of Market Close

As of December 11, 2025, 4:00 PM, CST, Dr. Reddy's Laboratories Limited’s stock price was $14.090.

Dr. Reddy's Laboratories Limited is up 1.66% from its previous closing price of $13.860.

During the last market session, Dr. Reddy's Laboratories Limited’s stock traded between $14.010 and $14.140. Currently, there are approximately 9.37 million shares outstanding for Dr. Reddy's Laboratories Limited.

Dr. Reddy's Laboratories Limited’s price-earnings (P/E) ratio is currently at 17.5, which is low compared to the Pharmaceuticals industry median of 19.9. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Dr. Reddy's Laboratories Limited Stock Price History

Dr. Reddy's Laboratories Limited’s (RDY) price is currently up 0.28% so far this month.

During the month of December, Dr. Reddy's Laboratories Limited’s stock price has reached a high of $14.210 and a low of $13.640.

Over the last year, Dr. Reddy's Laboratories Limited has hit prices as high as $16.170 and as low as $12.260. Year to date, Dr. Reddy's Laboratories Limited’s stock is down 10.77%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Dr. Reddy's Laboratories Limited Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 10, 2025, there were analysts who downgraded Dr. Reddy's Laboratories Limited’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Dr. Reddy's Laboratories Limited’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Dr. Reddy's Laboratories Limited’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Dr. Reddy's Laboratories Limited’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Dr. Reddy's Laboratories Limited (RDY) by visiting AAII Stock Evaluator.

Relative Price Strength of Dr. Reddy's Laboratories Limited

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 10, 2025, Dr. Reddy's Laboratories Limited has a weighted four-quarter relative price strength of -4.69%, which translates to a Momentum Score of 40 and is considered to be Weak.

Want to learn more about how Dr. Reddy's Laboratories Limited is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Dr. Reddy's Laboratories Limited Stock Price: Bottom Line

As of December 11, 2025, Dr. Reddy's Laboratories Limited’s stock price is $14.090, which is up 1.66% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Dr. Reddy's Laboratories Limited stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.